Nilotinib is effective in imatinib and sunitinib resistant GIST: a case report.
We report on the case of a 65-year-old male patient who had an imatinib- and sunitinib-resistant gastro-intestinal stromal tumor. Partial response was achieved with nilotinib treatment given in a compassionate-use program. Efficacy and tolerability of nilotinib in patients with refractory gastrointestinal stromal tumor are briefly discussed.